Day: November 7, 2019

Rockville, MD, Nov. 07, 2019 (GLOBE NEWSWIRE) —MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management will attend the following investor conferences in November:Credit Suisse 28th Annual Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and a fire-side chat with the analyst in Scottsdale, AZ on Tuesday, November 12, 2019, at 9:10 a.m. MT / 11:10 a.m. ET.Stifel 2019 Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and provide a corporate update in New York City on Wednesday, November 20, 2019, at 11:30 a.m. ET.Webcasts of the fire-side chat and corporate update may be...

San Antonio, Nov. 07, 2019 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a boutique registered investment advisory firm with longstanding experience in global markets and specialized sectors, today reported a net loss of $3.6 million, or $0.24 per share loss, for the quarter ended September 30, 2019. That’s compared to a net loss of $1.1 million, or $0.08 per share loss, for the same three-month period a year earlier. The increase in loss is primarily attributable to unrealized losses on corporate investments along with a decrease in operating revenue.Net unrealized losses on corporate investments in HIVE Blockchain Technologies Ltd. (“HIVE”) and GoldSpot Discoveries Corp. (“GoldSpot”) were major contributors to the net loss. The total unrealized losses recognized in the first fiscal quarter of 2020...

New York, NY, Nov. 07, 2019 (GLOBE NEWSWIRE) —  Stable Road Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 15,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Friday, November 8, 2019, under the ticker symbol “SRACU”. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade.  Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “SRAC” and “SRACW,” respectively.The...

WASHINGTON, Nov. 07, 2019 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN), today announced results from the Phase 3 HIMALAYAS trial evaluating roxadustat for the treatment of anemia in incident dialysis (ID) patients with chronic kidney disease (CKD), a clinically important subgroup of dialysis-dependent CKD patients.  Incident dialysis was defined as those who initiated dialysis within 4 months before randomization to roxadustat or epoetin alfa. In this trial of 1,043 patients, believed to be the largest trial to date investigating an anemia medicine in the ID population, roxadustat achieved both primary efficacy endpoints. The safety profile of roxadustat observed in the HIMALAYAS trial was consistent with results observed in previous roxadustat studies. This incident dialysis subpopulation is appropriate for comparison of roxadustat...

Record quarterly revenue of $20.7 million, up 31.1% year-over-yearWARSAW, Ind., Nov. 07, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30, 2019.Third Quarter & Recent Highlights                                                    Increased total revenue to $20.7 million for third quarter 2019, up 31.1% from $15.8 million in third quarter 2018Generated positive Adjusted EBITDA of $703 thousand for third quarter 2019, up from negative $127 thousand in third quarter 2018Increased the domestic sales organization to 158 consultants up 21.5% from third quarter 2018Deployed $13.7 million of consignment sets year-to-date, up 29.0% compared to $10.6...

TORONTO, Nov. 07, 2019 (GLOBE NEWSWIRE) — North American Palladium Ltd. (“NAP” or the”Company”) (TSX:PDL) (OTC PINK:PALDF) today announced financial and operational results for the three and nine months ended September 30, 2019.Third Quarter HighlightsRecord revenue: Based on 59,611 ounces of palladium sold at an average palladium price of US$1,587, revenue for the quarter increased to $149.9 million compared to $93.6 million for the same period in 2018. This is the highest quarterly revenue in the Company’s history. Revenue for the first nine months of the year was $413.8 million based on 172,507 payable ounces of palladium sold.Strong growth in net income: Net income was $41.4 million, or $0.70 per share, compared to $22.9 million, or $0.39 per share, reported for Q3 2018. Year-to-date net income was $107.5...

SAN CARLOS, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the company plans to present at the following conferences in November:Cowen’s 3rd Annual IO Next Summit in Maryland, Nov. 8, 2019Location: Gaylord National Resort and Convention CenterDate/Time: Friday, Nov. 8, at 9:30 a.m. ESTCredit Suisse 28th Annual Healthcare Conference in Scottsdale, Ariz., Nov. 11-13, 2019Location: The Phoenician, ScottsdaleDate/Time: Tuesday, Nov. 12, at 4:45 p.m. MSTStifel 2019 Healthcare Conference in New York, Nov. 19-21, 2019Location: Lotte New York Palace HotelDate/Time: Tuesday, Nov. 19, at 4:45 p.m. ESTJefferies 2019 London Healthcare Conference...

WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD), today announced that the Company will sponsor a Triferic (ferric pyrophosphate citrate) Exhibitor Spotlight presentation at the American Society of Nephrology (ASN) Kidney Week 2019 Conference in Washington, D.C. on Friday, November 8, 2019.In today’s clinical practice, it is very common to use traditional intravenous (IV) iron for repeated replacement of ongoing iron losses in chronic hemodialysis patients. This practice results in increased iron stores together with systemic inflammation.1 The long-range safety of such regular weekly or monthly traditional intravenous...

SANTA CLARA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Adesto Technologies Corporation (NASDAQ: IOTS), a leading provider of innovative application-specific semiconductors and systems for the Internet of Things (IoT), has received an ASPENCORE World Electronics Achievement Award (WEAA) for its FusionHD non-volatile memory (NVM) that provides advantages for next-generation IoT edge applications. The WEAA program honors companies and individuals who have made outstanding contributions to innovation and the development of the worldwide electronics industry.FusionHD NVM devices are designed specifically to support the code storage and data logging demands of feature-rich consumer and industrial IoT edge applications, delivering low power consumption, fast data transfer and robust, high-reliability operation. Compared to competitive NVM...

­Anu Gupta, Chief Operating Officer of Jyve Corp., brings background in innovation and operational excellenceKANSAS CITY, Mo., Nov. 07, 2019 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) announced today the appointment of Anuradha (Anu) Gupta, Chief Operating Officer of Jyve Corp., to its Board of Directors effective immediately, increasing its Board of Directors to 11.“I am pleased to welcome Anu to H&R Block’s Board of Directors,” said Robert A. Gerard, Chairman of the Board. “Her wealth of experience leading innovation, operational excellence and growth makes her the perfect addition to the Board as we guide the long-term strategy of the company and build enduring success. I look forward to her contributions as we serve the financial needs of consumers and small business owners.”Since 2018, Gupta has served as the Chief...